Best Health and Medical Grants in Guam

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The Limited Competition Small Grant Program supports NCATS CTSA Program KL2 scholars, enhancing their transition to independent academic translational scientists. This R03 funding facilitates various research projects, including pilot studies and methodology development, aimed at generating preliminary data for future R01 applications. The program is designed for short-term projects utilizing limited resources, promoting innovative research in clinical and translational science.

The NIH R25 program aims to enhance inclusivity in research education by supporting activities that encourage individuals from diverse backgrounds to pursue careers in substance use and addiction sciences. This initiative focuses on skills development courses and research experiences, particularly targeting underrepresented groups in biomedical and behavioral sciences. Applications are due by 5:00 PM local time of the applicant organization, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline.

This funding opportunity invites applications for a Research Coordinating Center (RCC) to lead a consortium aimed at optimizing anti-obesity medication (AOM) strategies for children and adolescents. The RCC will manage collaborative trials, focusing on developmental stages for AOM use, treatment effectiveness, and lifestyle interventions. By harmonizing data collection and analysis, the RCC aims to enhance research efforts and outcomes in combating youth obesity while ensuring safe AOM usage.

The Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs) program invites applications to enhance communication and collaboration among researchers in digestive and liver diseases. Funded by the NIDDK, DDRCCs focus on shared resources that foster productivity and innovative research ideas. Each center must revolve around a central theme aligned with the NIDDK's mission, ensuring effective research support while avoiding overlap with other NIH Institutes' funding areas.

This funding opportunity seeks clinical centers to test anti-obesity medication strategies for children and adolescents. The goal is to maximize benefits while minimizing risks associated with these medications. Proposed strategies should promote healthy growth, nutrition, physical activity, and mental well-being. Key areas of focus include determining optimal initiation stages for treatment, weight loss rates, and effective lifestyle therapies to support psychological and physical development, ensuring a collaborative approach in research and protocol development.

The NIH Instrumentation Grant Program for Resource-Limited Institutions supports the acquisition of advanced scientific instruments. This initiative aims to bolster biomedical research capabilities and educational opportunities at institutions that typically receive limited NIH Research Project Grant funding. By facilitating access to modern technology, the program enhances research quality and fosters innovation in healthcare and related fields.

This grant aims to address drug shortages by exploring the landscape of products susceptible to health fraud and finding ways for outsourcing facilities to fulfill these needs. By funding research and development, the initiative seeks to enhance the production of critical medications, thereby stabilizing the drug supply chain and protecting public health from fraud-related risks.

The Kenneth Rainin Foundation seeks to promote innovative research in Inflammatory Bowel Disease (IBD) by encouraging diverse perspectives from early career investigators and those underrepresented in science. The Innovator Awards do not require preliminary data and are evaluated based on the potential for innovation and scientific merit. Eligible researchers must hold advanced degrees and can apply for funding through their home institutions, fostering groundbreaking ideas that can transform IBD treatment and prevention.

Health services research organizations in Guam and other U.S. jurisdictions can apply for the Agency for Healthcare Research and Quality (AHRQ) Small Research Grant Program (R03), with awards up to US $200,000 for projects. Funding supports studies on healthcare quality, patient safety, delivery, and whole-person care across settings such as hospitals, primary care, home health, and emergency services.

The NIH Pathway to Independence Award (K99/R00) aims to enhance the career development of promising postdoctoral researchers by transitioning them into independent faculty positions. This program supports innovative research during the critical transition phase, enabling awardees to establish successful, independent research careers. Key application deadlines span from June 2024 to February 2027, with specific dates for standard, renewal, and AIDS-related applications. This initiative is vital for fostering a new generation of NIH-supported investigators.

Guam health and medical research institutions seeking costly, specialized equipment can access funding through the National Institutes of Health Basic Instrumentation Grant Program. Eligible NIH-supported investigator groups may request US $25,000 - US $350,000 to purchase a single new, commercially available instrument or integrated system, such as cell sorters, confocal microscopes, ultramicrotomes, gel imagers, or computer systems.

Guam health and medical institutions needing high-cost research equipment can access funding through the National Institutes of Health to purchase or upgrade a single, specialized instrument. Eligible projects include items like microscopes, biomedical imagers, mass spectrometers, and similar systems, with awards ranging from US $50,000 - US $750,000.

Health and medical organizations in Guam can access funding through the National Institutes of Health to purchase or upgrade a single high-end, specialized biomedical instrument or integrated system. Awards range from US $750,001 - US $2,000,000 for equipment such as spectrometers, microscopes, sequencers, flow cytometers, imaging systems, and other advanced medical research technologies.

Resource-limited biomedical research organizations in Guam and other eligible U.S. jurisdictions can seek funding to conduct research, strengthen their research environment, and build sponsored programs administration capacity. With a mission to expand participation in biomedical research, the National Institutes of Health provides awards up to US $2,500,000 for biology and health and medicine initiatives.

Guam health and medical organizations conducting biomedical research and advancing diversity, equity, inclusion, and accessibility may access funding through the National Institutes of Health. This ReWARD program supports both health-related research and DEIA activities of investigators without current NIH research project grants across the U.S. and eligible territories, including Guam.

Eligible U.S. institutions, including those in Guam, can apply for National Institutes of Health Ruth L. Kirschstein NRSA T32 awards to develop or enhance predoctoral and postdoctoral biomedical, behavioral, and clinical research training programs. Funding supports structured research, didactic, and career development activities that prepare a diverse workforce for impactful health and medical research careers.

Grants support late-stage biomedical graduate students from diverse backgrounds pursuing health and medicine research, including those studying in Guam, to complete their PhD and transition into mentored postdoctoral positions. Grants from the National Institutes of Health help build research careers through a two-phase F99/K00 award with structured mentoring, networking, and professional development activities.

Postdoctoral researchers in biology, health, or medical fields in Guam can apply for the NCI Pathway to Independence Award (K99/R00), with awards up to US $249,000 to support their transition to independent, tenure-track research careers. This National Institutes of Health program may benefit those pursuing advanced health and medical research pathways.

The Research Opportunities for New and At-Risk Investigators (R01 Clinical Trial Optional) program invites applications that promote workforce diversity in health-related sciences. This initiative encourages researchers from underrepresented backgrounds to propose independent research projects in alignment with NIH's mission. Important deadlines for standard and renewal applications range from February 2025 to November 2027. This effort aims to enhance diversity and inclusion within the scientific community.

The Academic Research Enhancement Award (AREA) supports small-scale research at institutions that receive limited NIH funding, emphasizing biomedical research for undergraduate students. This program aims to enhance the research environment and provide valuable experiences for students. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over four of the last seven years. This funding opportunity encourages investigator-initiated minimal risk clinical trials to advance NIH missions.

The NIMH Career Transition Award (K22) supports tenure-track intramural investigators at NIMH in their transition to independent research faculty positions. This program aims to foster innovative research in mental health, encouraging applicants with a strong record of research excellence. Key deadlines for applications vary, including those for standard and renewal submissions, emphasizing the importance of timely applications to secure funding and advance mental health research initiatives.

The Research Enhancement Award Program (REAP) aims to boost basic and clinical research at health professional and graduate schools that have historically received limited NIH funding. By supporting small-scale research projects led by faculty, REAP fosters student engagement in significant research endeavors, enhancing their educational experience. Eligible institutions must grant advanced degrees in health professions and have received under $6 million in NIH support in four of the last seven years, promoting broader participation in the nation's biomedical research efforts.

The Limited Competition K12 Mentored Research Career Development Program aims to support institutions in developing innovative career pathways for later-stage postdoctoral fellows and junior faculty. This initiative encourages applicants from those with existing Clinical and Translational Science Awards (CTSA) to foster independent research careers. By creating diverse opportunities across academia, industry, and government, the program enhances engagement in clinical and translational science research, ultimately contributing to significant advancements in health outcomes.

The Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional) aims to foster unique hub capabilities and research platforms to tackle critical gaps in clinical and translational science. Open to eligible organizations involved in the CTSA Program, this funding opportunity is crucial for laying groundwork for future advancements across CTSA Program Hubs. Applications are due by 5:00 PM local time, with Letters of Intent encouraged 30 days prior to the deadline.

The Limited Competition Small Grant Program under the NCATS CTSA aims to enhance the research capabilities of scholars transitioning to independent academic translational scientists. This program supports diverse clinical and translational science projects, including pilot studies and methodology development. The R03 grants are designed for short-term projects with limited resources that generate preliminary data for future R01 applications, thereby fostering innovation and advancing health research.

The Limited Competition: Clinical and Translational Science Award (CTSA) Program's Collaborative and Innovative Acceleration Award aims to enhance translational research by fostering collaboration in developing and implementing innovative solutions. This funding opportunity invites applications focused on new approaches and technologies that will improve research impact across various diseases and expedite treatment availability. Eligible applicants include organizations with active CTSA hub prime or partnering awards.